A carregar...

Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes?

Glycemic control has been considered a major therapeutic goal within the scope of diabetes management, as supported by robust observational and experimental evidence. However, the coexistence of micro and macrovascular disease is associated with the highest cardiovascular risks which highlights the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetol Metab Syndr
Main Authors: Moreira, Rodrigo Oliveira, Cobas, Roberta, Lopes Assis Coelho, Raquel C.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5883417/
https://ncbi.nlm.nih.gov/pubmed/29636825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13098-018-0327-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!